Taking more daily steps and engaging in moderate-to-vigorous physical activity may both be associated with a reduced risk of cardiovascular disease–related mortality among postmenopausal women with a ...
Eli Lilly's JAK inhibitor demonstrated 80% scalp hair regrowth in 42.4% of adolescents with severe alopecia areata after just 36 weeks of treatment, outperforming placebo in the Phase 3 BRAVE-AA-PEDS trial.
Researchers will present findings at the American Academy of Neurology’s 77th Annual Meeting on how OTC pain relievers may be linked to faster concussion recovery.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
"These differences were largely driven by the high rate of adverse events leading to study discontinuation in the OIT-treated participants, despite receiving omalizumab treatment at the initiation of therapy."
During the lecture, “Mitigating Malpractice: A Complete Guide for Optometrists,” Paul C. Ajamian, OD, discussed the seven reasons for malpractice lawsuits and provided nine tips on how ODs can avoid them.
A novel dumbbell-shaped thrombectomy device, called the Venus-TD, demonstrated high recanalization rates and favorable outcomes among patients with cerebral venous sinus thrombosis.